: Waiting for next track...

: Waiting for next track...

Further investment in cancer research

Further investment in cancer research

Published at 6:03am 15th January 2015. (Updated at 2:48pm 15th January 2015)

Yorkshire Cancer Research has announced more funding for pioneering projects across the region.

The charity's £1.1 million investment includes a three-year clinical trial at the University of Sheffield's Department of Oncology to discover how hormone levels affect the success of breast cancer treatments in post and pre-menopausal women.

The trial, involving 80 people, will help researchers establish how patients can be treated more effectively and develop new therapeutic strategies.

At the University of Leeds, a study into colorectal cancer - the second most common cancer in Yorkshire - will analyse whether treatment with a combination of aspirin and fish oil can benefit patients.

A natural compound found in oily fish called EPA is known to have anti-cancer properties with limited side effects.

The investment will also provide funding to employ a research nurse based at St James's University Hospital, Leeds, who will recruit bladder cancer patients for clinical trials and collect samples from them for further studies.

They will also develop patient support groups.

Another project will focus on the treatment of lung cancer, which has high incidence rates and low survival rates.

Using samples from 100 patients, researchers at the University of Sheffield's Department of Oncology are planning to test a class of drugs to see whether they can be used to make cancer cells more sensitive to radiotherapy treatment.

A further £5 million of funding will be announced in the next few weeks as part of the charity's new strategy to prevent, diagnose and treat cancer more effectively in Yorkshire.

Dr Kathryn Scott, Head of Research Funding, said: "We are extremely pleased to be able to announce another significant investment in patient-focused research.

"The way to get new therapies and treatments into clinical practice is to fund research which tests the new treatments on patients directly so that we can ensure the findings made in the lab are translatable to humans.

"National funding for cancer research in Yorkshire lags behind many other regions and Yorkshire Cancer Research is increasing its commitment to the region. We know patients do better when treated by research active centres and when they are involved in clinical trials.

"We are committed to bringing pioneering treatments to the region and many of the projects funded by this investment could progress to further trials."